ResMed Logo

Noninvasive ventilation for acute respiratory failure

Noninvasive ventilation (NIV) is often used for patients with Chronic Obstructive Pulmonary Disease (COPD) and acute cardiogenic pulmonary oedema.1,2  However, there is emerging evidence that NIV can be used successfully in treating other types of acute respiratory failure.

NIV has already been employed for patients with acute hypoxemic respiratory failure. In selected patient groups it may:

  • Avoid the need for intubation in >50% of selected patients3,2
  • Allow for earlier extubation of mechanically ventilated patients3
  • Reduce mortality2,3,4,5
  • Reduce the occurrence of nosocomial pneumonia3

Some predictors of respiratory failure include lower levels of consciousness, lower pH, and increased secretions2. Patient groups where evidence is still lacking include asthma, pneumonia, and acute lung injury.6


Find out more about noninvasive ventilation on our dedicated ResMed page

More Articles

Noninvasive ventilation for COPD patients
Treatment of COPD with noninvasive ventilation (NIV) has been shown to be effective in treating acute exacerbations of COPD, assisting pulmonary rehabilitation in COPD patients, and providing benefits in managing chronic hypercapnic COPD patients.
Noninvasive ventilation for neuromusclar diseases in adults
Many chronic neuromuscular disorders lead to progressive respiratory muscle dysfunction. Non-invasive ventilation can help reduce daytime sleepiness while facilitating gas exchange and breathing.
Noninvasive ventilation for obesity hypoventilation syndrome
Non-invasive ventilation in patients with obesity hypoventilation syndrome has been shown to normalise blood gases, prolong survival and increase exercise capacity.